305 related articles for article (PubMed ID: 23329897)
1. The practical management of treatment failure in chronic hepatitis C: a summary of current research and management options for refractory patients.
Hassanein T; Shiffman ML; Zein NN
Gastroenterol Hepatol (N Y); 2007 Jun; 3(6 Suppl 20):4-32. PubMed ID: 23329897
[No Abstract] [Full Text] [Related]
2. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
[TBL] [Abstract][Full Text] [Related]
3. A Practical Approach to Refractory Chronic Rhinosinusitis.
McCoul ED; Tabaee A
Otolaryngol Clin North Am; 2017 Feb; 50(1):183-198. PubMed ID: 27888913
[TBL] [Abstract][Full Text] [Related]
4. Resistance to hepatitis C virus. Implications and therapeutic options.
Llerena S; Cabezas J; Iruzubieta P; Crespo J
Gastroenterol Hepatol; 2017; 40(7):484-494. PubMed ID: 28647053
[TBL] [Abstract][Full Text] [Related]
5. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
[TBL] [Abstract][Full Text] [Related]
6. Management of Hepatitis C: A Practical Primer for Nurses.
Guss D; Sherigar J; Mohanty SR
Gastroenterol Nurs; 2020; 43(1):22-27. PubMed ID: 31913958
[TBL] [Abstract][Full Text] [Related]
7. New hepatitis C virus therapies: drug classes and metabolism, drug interactions relevant in the transplant settings, drug options in decompensated cirrhosis, and drug options in end-stage renal disease.
Kwo PY; Badshah MB
Curr Opin Organ Transplant; 2015 Jun; 20(3):235-41. PubMed ID: 25944238
[TBL] [Abstract][Full Text] [Related]
8. Viral hepatitis in elderly haemodialysis patients: current prevention and management strategies.
Girndt M
Drugs Aging; 2008; 25(10):823-40. PubMed ID: 18808207
[TBL] [Abstract][Full Text] [Related]
9. Current Management of Chronic Hepatitis B and C in Chronic Kidney Disease.
Mikolajczyk AE; Aronsohn AI
Adv Chronic Kidney Dis; 2015 Sep; 22(5):352-60. PubMed ID: 26311596
[TBL] [Abstract][Full Text] [Related]
10. Treatment of chronic viral hepatitis in patients with renal disease.
Fabrizi F; Martin P; Bunnapradist S
Gastroenterol Clin North Am; 2004 Sep; 33(3):655-70, xi. PubMed ID: 15324949
[TBL] [Abstract][Full Text] [Related]
11. Treatment failure in coeliac disease: a practical guide to investigation and treatment of non-responsive and refractory coeliac disease.
Mooney PD; Evans KE; Singh S; Sanders DS
J Gastrointestin Liver Dis; 2012 Jun; 21(2):197-203. PubMed ID: 22720310
[TBL] [Abstract][Full Text] [Related]
12. Advances in hepatitis B and C.
Thomson EC; Main J
Curr Opin Infect Dis; 2004 Oct; 17(5):449-59. PubMed ID: 15353965
[TBL] [Abstract][Full Text] [Related]
13. Advances in chronic viral hepatitis.
Hui AY; Sung JJ
Curr Opin Infect Dis; 2005 Oct; 18(5):400-6. PubMed ID: 16148526
[TBL] [Abstract][Full Text] [Related]
14. Management of Chronic Hepatitis C in End-stage Renal Disease.
Angulo-Diaz V; Lim JK; Martin P; Liapakis A
J Clin Gastroenterol; 2018 Apr; 52(4):287-294. PubMed ID: 29099465
[TBL] [Abstract][Full Text] [Related]
15. Management of patients refractory to platelet transfusion.
Sacher RA; Kickler TS; Schiffer CA; Sherman LA; Bracey AW; Shulman IA;
Arch Pathol Lab Med; 2003 Apr; 127(4):409-14. PubMed ID: 12683867
[TBL] [Abstract][Full Text] [Related]
16. Management of chronic hepatitis B in treatment-experienced patients.
Hui CK; Zhang HY; Lau GK
Gastroenterol Clin North Am; 2004 Sep; 33(3):601-16, x. PubMed ID: 15324946
[TBL] [Abstract][Full Text] [Related]
17. Approach and management of patients with chronic hepatitis B and C during the course of inflammatory bowel disease.
Coban S; Kekilli M; Köklü S
Inflamm Bowel Dis; 2014 Nov; 20(11):2142-50. PubMed ID: 25072501
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of entecavir in lamivudine-refractory patients with chronic hepatitis B: randomized controlled trial in Japanese patients.
Suzuki F; Toyoda J; Katano Y; Sata M; Moriyama M; Imazeki F; Kage M; Seriu T; Omata M; Kumada H
J Gastroenterol Hepatol; 2008 Sep; 23(9):1320-6. PubMed ID: 18554238
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C Virus and Antiviral Drug Resistance.
Kim S; Han KH; Ahn SH
Gut Liver; 2016 Nov; 10(6):890-895. PubMed ID: 27784846
[TBL] [Abstract][Full Text] [Related]
20. Treatment options for HCV nonresponders and relapse patients.
Pearlman BL; Sjogren MH
Gastroenterol Hepatol (N Y); 2010 Mar; 6(3 Suppl 6):1-12. PubMed ID: 20567569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
